IAS
PRME icon

Integrity Advisory Solutions’s Prime Medicine PRME Stock Holding History

Integrity Advisory Solutions’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,689
Closed -$40.6K – 304
2025
Q4 		$40.6K Buy
+11,689
New +$52K 0.01% 263

Other funds holding PRME

Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Integrity Advisory Solutions's PRME Position: Q1 2026 in Review

Integrity Advisory Solutions sold out of Prime Medicine (PRME) in Q1 2026, closing a stake of 11,689 shares — an estimated $40.6K sold.

Integrity Advisory Solutions first reported a position in PRME in Q4 2025 and held it in 1 quarter. The position peaked at $40.6K in Q4 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Integrity Advisory Solutions reported no remaining Prime Medicine position as of Q1 2026 after selling out during the quarter.
  • Integrity Advisory Solutions sold 11,689 Prime Medicine shares in Q1 2026, an estimated $40.6K.
  • Integrity Advisory Solutions first reported a position in Prime Medicine in Q4 2025 and held it in 1 quarter.
  • Integrity Advisory Solutions's Prime Medicine position peaked at $40.6K in Q4 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Integrity Advisory Solutions's 13F filing for Q1 2026, filed 11 May 2026.